Detalhe da pesquisa
1.
Spatial predictors of immunotherapy response in triple-negative breast cancer.
Nature
; 621(7980): 868-876, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674077
2.
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer.
Breast Cancer Res Treat
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38874685
3.
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Ann Surg Oncol
; 31(2): 957-965, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947974
4.
Controversies in axillary management of patients with breast cancer - updates for 2024.
Curr Opin Obstet Gynecol
; 36(1): 51-56, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678325
5.
Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.
Ann Surg
; 275(3): 576-581, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32657944
6.
Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958).
Breast Cancer Res Treat
; 196(2): 311-321, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094611
7.
Magnetic resonance imaging system for intraoperative margin assessment for DCIS and invasive breast cancer using the ClearSight™ system in breast-conserving surgery-Results from a postmarketing study.
J Surg Oncol
; 125(3): 361-368, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724205
8.
PERFORM: a non-interventional study assessing the patients' treatment starting with 1L palbociclib in HR+/HER2- ABC.
Future Oncol
; 18(36): 3971-3982, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427183
9.
Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis.
Br J Cancer
; 123(1): 33-37, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367072
10.
ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment-A New Concept.
Ann Surg Oncol
; 31(2): 1033-1034, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38093166
11.
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA).
Anticancer Drugs
; 30(4): 394-401, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30875348
12.
Biosimilars: what the oncologist should know.
Future Oncol
; 15(10): 1147-1165, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793950
13.
RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.
BMC Cancer
; 18(1): 851, 2018 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30144818
14.
Intraoperative assessment of margins in breast conservative surgery--still in use?
J Surg Oncol
; 110(1): 15-20, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24863286
15.
App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship - a multicentric randomized controlled trial.
Front Oncol
; 14: 1354377, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38699636
16.
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs.
Geburtshilfe Frauenheilkd
; 84(5): 443-458, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817598
17.
Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA).
Breast
; 72: 103575, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37690320
18.
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare.
Geburtshilfe Frauenheilkd
; 83(6): 673-685, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614683
19.
Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer.
EClinicalMedicine
; 55: 101756, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36457648
20.
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial.
Clin Cancer Res
; 29(22): 4606-4612, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725572